Stock price history for Alnylam Pharmaceuticals (ALNY)

Highest end of day price: 431,83 € Euro on 2025-10-20

Lowest end of day price: 3,47 € Euro on 2004-08-16

Stock price history of Alnylam Pharmaceuticals from 2004 to 2026

Annual Stock Price Performance

Year	Performance
2026	-29.99%
2025	70.21%
2024	20.72%
2023	-18.06%
2022	36.65%
2021	32.38%
2020	12.41%
2019	58.29%
2018	-44.70%
2017	228.80%
2016	-59.75%
2015	-3.71%
2014	51.89%
2013	235.42%
2012	110.74%
2011	-18.58%
2010	-45.64%
2009	-29.94%
2008	-14.49%
2007	34.82%
2006	65.12%
2005	75.73%
2004	6.71%

Stock price for similar companies or competitors

Company	Stock price	Change 1d%	Country
Novartis NVS	137,24 €	0.71%	🇨🇭 Switzerland
Sanofi SNY	38,68 €	1.50%	🇫🇷 France
Regeneron Pharmaceuticals REGN	586,51 €	1.70%	🇺🇸 USA
Sarepta Therapeutics SRPT	13,97 €	1.34%	🇺🇸 USA
Regulus Therapeutics RGLS	7,17 €	0.00%	🇺🇸 USA
OPKO Health OPK	1,09 €	1.64%	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	27,32 €	0.88%	🇮🇱 Israel
Arrowhead Pharmaceuticals ARWR	75,19 €	-0.08%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions